Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Feature Previous | All Articles This Week | Next
This article originally posted 15 June, 2012 and appeared in  GLP-1 Receptor Agonist TherapySpecial Edition - Keeping Patients on Track with GLP-1

A Primary Care Physician's Perspective: Dr. Norris Brown, Austin, TX

When the GLP-1 analogs first came out I was slow to start using them. As a primary care physician in a busy multi-practitioner office I was used to working with oral medications for diabetes, and only as a last resort would I put patients on basal insulin. If my patients needed to have more intense glucose management I would refer them to an endocrinologist in our building. Over the years I watched as my practice colleagues used more of the GLP-1 analogs and so I started using them based on the results that my partners were having.....
Advertisement
It has become easy over the past couple of years to get my patients to start on these medications, and with the advent of once daily dosing the job has gotten even easier. 

I find that many of my patients stay on the medications because of the results that they get. When patients come back for their first follow-up after starting the on the GLP-1 analog, I have one of my medical assistants fill out a sheet with the important information I think keeps the patient on the medication.

This sheet lists the patient's A1c for the past 3 appointments and their current A1c. This gives the patient the opportunity to see that the addition of a GLP-1 analog has stopped the rise in A1c and, in fact, lowered it. The sheet also contains the patient's weight for the past 3 visits so that they can see that the GLP-1 analog has stopped the weight gain they had been experiencing and in many cases has even caused them to lose weight.

Our biggest battle in keeping our patients on GLP-1 analog therapy has been the insurance companies. Although they seem to have good formulary coverage for these products the co-pays are often very high. We are also in an area where a lot of patients are not insured and so the cost of these medications can be prohibitive. In both of these cases I will give the patient samples for the first month and then if the copay is high I will supply them with samples every other month in order to make the effective cost of a month's supply half of what it could be. This method seems to have a positive effect on the patient and often times this is all that it takes to get the patient to stay on the product.

 
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 15 June, 2012 and appeared in  GLP-1 Receptor Agonist TherapySpecial Edition - Keeping Patients on Track with GLP-1

Past five issues: Issue 677 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 | Diabetes Clinical Mastery Series Issue 135 | Issue 675 |

2013 Most Popular Articles:

AACE Releases New Comprehensive Diabetes Management Algorithm
Posted April 25, 2013
AACE - New Diabetes Guidelines Based on Tailored Approach
Posted May 09, 2013
Discovery Raises Hope for Type 1 Diabetes Reversal
Posted May 03, 2013
AACE: Ralph A. DeFronzo, MD -- Diabetes Prevention Supports More Aggressive and Earlier Intervention
Posted May 09, 2013
Intermittent Fasting May Improve Diabetes and Reduce Cardiovascular Risk
Posted May 03, 2013
AACE – New Test Efficiently Detects Diabetic Neuropathy
Posted May 09, 2013
AACE: CAD Risk for Pre-Diabetes Similar to Diabetes
Posted May 09, 2013
Low-Glycemic Diet Seen to Reverse Diastolic Dysfunction of Diabetes
Posted May 03, 2013
New Pill in the Works for Type 1 Patients
Posted April 19, 2013
New Updated Hypoglycemia Classifications
Posted April 19, 2013

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control



Search Articles On Diabetes In Control